![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: HMG20A |
Gene summary for HMG20A |
![]() |
Gene information | Species | Human | Gene symbol | HMG20A | Gene ID | 10363 |
Gene name | high mobility group 20A | |
Gene Alias | HMGX1 | |
Cytomap | 15q24.3 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | Q9NP66 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10363 | HMG20A | HTA11_3410_2000001011 | Human | Colorectum | AD | 7.67e-06 | -3.79e-01 | 0.0155 |
10363 | HMG20A | HTA11_866_3004761011 | Human | Colorectum | AD | 3.00e-05 | -4.17e-01 | 0.096 |
10363 | HMG20A | HTA11_10711_2000001011 | Human | Colorectum | AD | 1.77e-02 | -4.28e-01 | 0.0338 |
10363 | HMG20A | HTA11_7696_3000711011 | Human | Colorectum | AD | 5.01e-03 | -3.69e-01 | 0.0674 |
10363 | HMG20A | HTA11_99999970781_79442 | Human | Colorectum | MSS | 5.62e-06 | -3.82e-01 | 0.294 |
10363 | HMG20A | HTA11_99999971662_82457 | Human | Colorectum | MSS | 1.49e-05 | -3.97e-01 | 0.3859 |
10363 | HMG20A | HTA11_99999974143_84620 | Human | Colorectum | MSS | 5.32e-09 | -4.53e-01 | 0.3005 |
10363 | HMG20A | A015-C-203 | Human | Colorectum | FAP | 1.34e-12 | -3.29e-01 | -0.1294 |
10363 | HMG20A | A015-C-204 | Human | Colorectum | FAP | 1.74e-06 | -4.06e-01 | -0.0228 |
10363 | HMG20A | A002-C-201 | Human | Colorectum | FAP | 8.87e-14 | -4.25e-01 | 0.0324 |
10363 | HMG20A | A001-C-119 | Human | Colorectum | FAP | 7.53e-07 | -4.59e-01 | -0.1557 |
10363 | HMG20A | A001-C-108 | Human | Colorectum | FAP | 4.07e-11 | -3.71e-01 | -0.0272 |
10363 | HMG20A | A002-C-205 | Human | Colorectum | FAP | 9.25e-15 | -4.27e-01 | -0.1236 |
10363 | HMG20A | A015-C-005 | Human | Colorectum | FAP | 6.03e-05 | -3.49e-01 | -0.0336 |
10363 | HMG20A | A015-C-006 | Human | Colorectum | FAP | 1.53e-11 | -4.70e-01 | -0.0994 |
10363 | HMG20A | A015-C-106 | Human | Colorectum | FAP | 1.32e-07 | -3.59e-01 | -0.0511 |
10363 | HMG20A | A002-C-114 | Human | Colorectum | FAP | 1.19e-14 | -4.67e-01 | -0.1561 |
10363 | HMG20A | A015-C-104 | Human | Colorectum | FAP | 3.65e-17 | -4.57e-01 | -0.1899 |
10363 | HMG20A | A001-C-014 | Human | Colorectum | FAP | 1.01e-06 | -3.55e-01 | 0.0135 |
10363 | HMG20A | A002-C-016 | Human | Colorectum | FAP | 1.94e-15 | -4.10e-01 | 0.0521 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:1903320 | Colorectum | AD | regulation of protein modification by small protein conjugation or removal | 86/3918 | 242/18723 | 9.43e-08 | 4.65e-06 | 86 |
GO:1903321 | Colorectum | AD | negative regulation of protein modification by small protein conjugation or removal | 37/3918 | 95/18723 | 4.49e-05 | 7.83e-04 | 37 |
GO:0006325 | Colorectum | AD | chromatin organization | 119/3918 | 409/18723 | 4.85e-05 | 8.33e-04 | 119 |
GO:19033202 | Colorectum | MSS | regulation of protein modification by small protein conjugation or removal | 82/3467 | 242/18723 | 7.49e-09 | 4.63e-07 | 82 |
GO:19033212 | Colorectum | MSS | negative regulation of protein modification by small protein conjugation or removal | 36/3467 | 95/18723 | 7.10e-06 | 1.82e-04 | 36 |
GO:00063252 | Colorectum | MSS | chromatin organization | 107/3467 | 409/18723 | 7.22e-05 | 1.21e-03 | 107 |
GO:19033204 | Colorectum | FAP | regulation of protein modification by small protein conjugation or removal | 61/2622 | 242/18723 | 2.36e-06 | 9.21e-05 | 61 |
GO:00063253 | Colorectum | FAP | chromatin organization | 84/2622 | 409/18723 | 1.62e-04 | 2.47e-03 | 84 |
GO:19033214 | Colorectum | FAP | negative regulation of protein modification by small protein conjugation or removal | 25/2622 | 95/18723 | 1.10e-03 | 1.06e-02 | 25 |
GO:19033205 | Colorectum | CRC | regulation of protein modification by small protein conjugation or removal | 51/2078 | 242/18723 | 4.55e-06 | 1.87e-04 | 51 |
GO:19033215 | Colorectum | CRC | negative regulation of protein modification by small protein conjugation or removal | 26/2078 | 95/18723 | 9.16e-06 | 3.19e-04 | 26 |
GO:00063254 | Colorectum | CRC | chromatin organization | 74/2078 | 409/18723 | 1.48e-05 | 4.61e-04 | 74 |
GO:1903320113 | Thyroid | PTC | regulation of protein modification by small protein conjugation or removal | 148/5968 | 242/18723 | 4.49e-21 | 8.10e-19 | 148 |
GO:00182059 | Thyroid | PTC | peptidyl-lysine modification | 188/5968 | 376/18723 | 1.34e-13 | 7.09e-12 | 188 |
GO:1903321113 | Thyroid | PTC | negative regulation of protein modification by small protein conjugation or removal | 59/5968 | 95/18723 | 1.26e-09 | 3.63e-08 | 59 |
GO:000632520 | Thyroid | PTC | chromatin organization | 183/5968 | 409/18723 | 2.55e-08 | 5.70e-07 | 183 |
GO:00169256 | Thyroid | PTC | protein sumoylation | 30/5968 | 53/18723 | 1.71e-04 | 1.31e-03 | 30 |
GO:190332034 | Thyroid | ATC | regulation of protein modification by small protein conjugation or removal | 152/6293 | 242/18723 | 9.76e-21 | 1.71e-18 | 152 |
GO:001820516 | Thyroid | ATC | peptidyl-lysine modification | 193/6293 | 376/18723 | 6.92e-13 | 3.06e-11 | 193 |
GO:190332135 | Thyroid | ATC | negative regulation of protein modification by small protein conjugation or removal | 60/6293 | 95/18723 | 3.53e-09 | 8.14e-08 | 60 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HMG20A | SNV | Missense_Mutation | novel | c.893N>A | p.Ser298Asn | p.S298N | Q9NP66 | protein_coding | tolerated(0.29) | benign(0.003) | TCGA-38-4627-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
HMG20A | SNV | Missense_Mutation | c.665N>T | p.Thr222Ile | p.T222I | Q9NP66 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-78-7149-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
HMG20A | SNV | Missense_Mutation | c.961N>T | p.His321Tyr | p.H321Y | Q9NP66 | protein_coding | deleterious(0.04) | benign(0.248) | TCGA-L9-A7SV-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | CR | |
HMG20A | SNV | Missense_Mutation | novel | c.537N>G | p.Phe179Leu | p.F179L | Q9NP66 | protein_coding | tolerated(0.14) | possibly_damaging(0.717) | TCGA-22-5479-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | carboplatin | SD |
HMG20A | SNV | Missense_Mutation | c.1036N>T | p.Asp346Tyr | p.D346Y | Q9NP66 | protein_coding | deleterious(0) | possibly_damaging(0.906) | TCGA-43-6770-01 | Lung | lung squamous cell carcinoma | Female | <65 | I/II | Vaccine | recprame+as15 | SD | |
HMG20A | SNV | Missense_Mutation | novel | c.598G>T | p.Ala200Ser | p.A200S | Q9NP66 | protein_coding | tolerated(0.65) | benign(0.007) | TCGA-85-8276-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD |
HMG20A | SNV | Missense_Mutation | novel | c.386N>T | p.Pro129Leu | p.P129L | Q9NP66 | protein_coding | deleterious(0) | possibly_damaging(0.823) | TCGA-90-A4ED-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
HMG20A | SNV | Missense_Mutation | novel | c.985N>A | p.Gln329Lys | p.Q329K | Q9NP66 | protein_coding | tolerated(0.79) | benign(0.031) | TCGA-CN-6010-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD |
HMG20A | SNV | Missense_Mutation | rs868384861 | c.781N>T | p.Arg261Cys | p.R261C | Q9NP66 | protein_coding | deleterious(0.03) | possibly_damaging(0.872) | TCGA-XK-AAIW-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | PD |
HMG20A | SNV | Missense_Mutation | rs776748953 | c.85A>G | p.Thr29Ala | p.T29A | Q9NP66 | protein_coding | tolerated_low_confidence(0.72) | benign(0) | TCGA-CG-5721-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |